We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.03B
AUM Growth
-$830M
Cap. Flow
-$81.5M
Cap. Flow %
-2.02%
Top 10 Hldgs %
32.81%
Holding
196
New
10
Increased
93
Reduced
75
Closed
18

Top Buys

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$40.4M
2
ETSY icon
Etsy
ETSY
+$38.1M
3
PRCH icon
Porch Group
PRCH
+$33.7M
4
COUP
Coupa Software Incorporated
COUP
+$31.5M
5
CHGG icon
Chegg
CHGG
+$29.5M

Top Sells

Rank Stock Value
1
WK icon
Workiva
WK
+$64.7M
2
TWOU
2U Inc
TWOU
+$40.8M
3
CRCT icon
Cricut
CRCT
+$39.3M
4
GLOB icon
Globant
GLOB
+$24.4M
5
FLEX icon
Flex
FLEX
+$24M

Sector Composition

Rank Sector Weight
1 Technology 35.39%
2 Healthcare 19.87%
3 Industrials 14.49%
4 Consumer Discretionary 11.64%
5 Communication Services 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSSE
101
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$8.34M 0.21%
1,043,916
+38,723
+4% +$404K
LXFR icon
102
Luxfer Holdings
LXFR
$457M
$8.21M 0.2%
488,607
-440,183
-47% -$7.79M
PTLO icon
103
Portillo's
PTLO
$327M
$8.09M 0.2%
329,336
+242,283
+278% +$6.42M
INSM icon
104
Insmed
INSM
$29B
$8.08M 0.2%
343,877
+38,214
+13% +$888K
XENE icon
105
Xenon Pharmaceuticals
XENE
$6.13B
$8.03M 0.2%
262,705
+45,404
+21% +$1.36M
FATE icon
106
Fate Therapeutics
FATE
$316M
$7.95M 0.2%
204,945
+71,544
+54% +$2.77M
APLS
107
DELISTED
Apellis Pharmaceuticals
APLS
$7.82M 0.19%
153,923
+70,322
+84% +$3.1M
HDSN
108
Hudson Technologies
HDSN
$236M
$7.77M 0.19%
1,250,975
-577,985
-32% -$2.56M
BCRX icon
109
BioCryst Pharmaceuticals
BCRX
$2.66B
$7.63M 0.19%
469,430
-661,148
-58% -$10.6M
CIEN icon
110
Ciena
CIEN
$54.7B
$7.54M 0.19%
124,332
-1,645
-1% -$108K
ACTG icon
111
Acacia Research
ACTG
$452M
$7.46M 0.19%
1,653,869
-699,825
-30% -$2.94M
ONTO icon
112
Onto Innovation
ONTO
$15.5B
$7.46M 0.19%
85,846
+2,150
+3% +$191K
KNSA icon
113
Kiniksa Pharmaceuticals
KNSA
$6.05B
$7.38M 0.18%
742,158
+142,636
+24% +$1.51M
WIX icon
114
WIX.com
WIX
$2.77B
$7.35M 0.18%
70,347
+1,980
+3% +$216K
SKIN icon
115
SkinHealth Systems
SKIN
$87.3M
$7.16M 0.18%
423,994
+250,770
+145% +$4.14M
RCUS icon
116
Arcus Biosciences
RCUS
$3.68B
$7.13M 0.18%
226,050
+88,663
+65% +$2.97M
AMWL icon
117
American Well
AMWL
$225M
$7.1M 0.18%
84,375
+13,602
+19% +$1.15M
NTNX icon
118
Nutanix
NTNX
$17.3B
$7M 0.17%
261,055
+18,685
+8% +$501K
QLYS icon
119
Qualys
QLYS
$6.4B
$6.78M 0.17%
47,633
+1,501
+3% +$192K
NTLA icon
120
Intellia Therapeutics
NTLA
$1.68B
$6.73M 0.17%
92,609
-23,174
-20% -$1.96M
AXTI icon
121
AXT Inc
AXTI
$4.76B
$6.65M 0.17%
947,901
+112,496
+13% +$846K
ATRC icon
122
AtriCure
ATRC
$2.18B
$6.48M 0.16%
98,611
-15,676
-14% -$1.02M
RUSHA icon
123
Rush Enterprises Class A
RUSHA
$9.46B
$6.42M 0.16%
189,065
-206,775
-52% -$7.27M
BEAM icon
124
Beam Therapeutics
BEAM
$2.79B
$6.2M 0.15%
108,227
+24,835
+30% +$1.63M
THRM icon
125
Gentherm
THRM
$1.28B
$6.01M 0.15%
82,256
-141,268
-63% -$11.8M
3 4
5
6 7

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Granahan Investment Management held 196 positions worth $4.03B, down 17% from $4.86B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Granahan Investment Management's Q1 2022 filing shows 10 new, 93 increased, 75 reduced and 18 closed positions. Its largest new stake was Coupa Software Incorporated: 260,383 shares worth $26.5M. The largest sale was Workiva, an estimated $64.7M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q1 2022 buy was Coupa Software Incorporated: 260,383 shares worth $26.5M.
  • Granahan Investment Management added most to CoStar Group in Q1 2022, an estimated $40.4M increase.
  • Granahan Investment Management's biggest Q1 2022 reduction was Workiva, cutting an estimated $64.7M.
  • Granahan Investment Management fully exited 2U Inc in Q1 2022, selling an estimated $40.8M.
  • Granahan Investment Management's ten largest holdings make up 33% of its $4.03B portfolio in Q1 2022.
  • Granahan Investment Management opened 10 new positions and closed 18 in Q1 2022.
  • Granahan Investment Management's portfolio value fell 17% quarter-over-quarter to $4.03B.

Based on Granahan Investment Management's 13F filing for Q1 2022, filed 16 May 2022.